Mouse CCL8/MCP-2 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF790
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Cited:
Human, Mouse
Applications
Validated:
Western Blot
Cited:
Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Flow Cytometry
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant mouse CCL8/MCP-2
Glu20-Pro97
Accession # Q9Z121
Glu20-Pro97
Accession # Q9Z121
Specificity
Detects mouse CCL8/MCP‑2 in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant human (rh) MCP-2 and recombinant mouse (rm) MCP-5 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Mouse CCL8/MCP-2 Antibody
Detection of CCL8/MCP-2 by Western Blot
CD62L+ KCs induce NETosis by CCL8.a NETosis of murine primary neutrophils cultured with CM of untreated KCs, KCs pretreated with LvM16 CM, or CM of the pretreated KCs, or CM of LvM16 (zoomed areas shown at bottom). b NETosis of murine primary neutrophils cultured in CM of total KCs or CD62L+ KCs. c Expression heatmap of secreted protein-encoding genes in KC subclusters. d NETosis of neutrophils cultured with recombinant CCL8 (1 ng/mL), SAA1 or SAA3 (10 ng/mL) or PMA (20 nM) for 16 h. e mRNA and protein expression of Ccl8 in CD62L+ and CD62L– KCs isolated from LvM16 liver metastases of mice. Relative quantitation of blot intensity normalized to loading control was provided below each blot. f NETosis of neutrophils cultured with CM of KCs from WT or Ccl8–/– mice. The KCs were pretreated with CM of LvM16. g, h ERK phosphorylation and NETosis quantitation by IF analysis of murine neutrophils treated with PMA, recombinant CCL8 (10 ng/mL) and/or the ERK inhibitor SCH772984 (SCH, 1 μM) for 16 h. i ERK phosphorylation and NETosis of neutrophils treated with CCL8 (10 ng/mL) and/or the CCR1 antagonist BX471 (1 nM) for 16 h. j GO analyses of the upregulated genes in rCCL8-treated vs untreated neutrophils. n = 3 (a, e, h, i), 4 (b, d, f) biological repeats per group. Scale bars, 50 μm. P values were obtained by two-tailed unpaired t-test. Data are shown as mean ± SD. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/40796724), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of CCL8/MCP-2 by Western Blot
CD62L+ KCs induce NETosis by CCL8.a NETosis of murine primary neutrophils cultured with CM of untreated KCs, KCs pretreated with LvM16 CM, or CM of the pretreated KCs, or CM of LvM16 (zoomed areas shown at bottom). b NETosis of murine primary neutrophils cultured in CM of total KCs or CD62L+ KCs. c Expression heatmap of secreted protein-encoding genes in KC subclusters. d NETosis of neutrophils cultured with recombinant CCL8 (1 ng/mL), SAA1 or SAA3 (10 ng/mL) or PMA (20 nM) for 16 h. e mRNA and protein expression of Ccl8 in CD62L+ and CD62L– KCs isolated from LvM16 liver metastases of mice. Relative quantitation of blot intensity normalized to loading control was provided below each blot. f NETosis of neutrophils cultured with CM of KCs from WT or Ccl8–/– mice. The KCs were pretreated with CM of LvM16. g, h ERK phosphorylation and NETosis quantitation by IF analysis of murine neutrophils treated with PMA, recombinant CCL8 (10 ng/mL) and/or the ERK inhibitor SCH772984 (SCH, 1 μM) for 16 h. i ERK phosphorylation and NETosis of neutrophils treated with CCL8 (10 ng/mL) and/or the CCR1 antagonist BX471 (1 nM) for 16 h. j GO analyses of the upregulated genes in rCCL8-treated vs untreated neutrophils. n = 3 (a, e, h, i), 4 (b, d, f) biological repeats per group. Scale bars, 50 μm. P values were obtained by two-tailed unpaired t-test. Data are shown as mean ± SD. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/40796724), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Mouse CCL8/MCP-2 Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Mouse CCL8/MCP-2
Sample: Recombinant Mouse CCL8/MCP-2
Reviewed Applications
Read 1 review rated 4 using AF790 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL8/MCP-2
Alternate Names
MCP-2, MCP2
Gene Symbol
CCL8
UniProt
Additional CCL8/MCP-2 Products
Product Documents for Mouse CCL8/MCP-2 Antibody
Product Specific Notices for Mouse CCL8/MCP-2 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...